FDA Approved: LEXISCAN — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved a supplemental labeling change for Lexiscan (regadenoson) from Astellas Pharma US, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Ischemia

Drugs mentioned

• Lexiscan (regadenoson)

Snippet

SUPPL AP for LEXISCAN (REGADENOSON)